Targeting Cancer Cells with Next-Generation Therapies

Exploring the challenges in traditional cancer treatments and the potential of next-generation cell therapies that target specific properties of cancer cells to minimize collateral damage. The chapter discusses the high mutation rate of cancer cells and the opportunities it presents for tailored treatments, focusing on the evolution and effectiveness of immunotherapy in leveraging the immune system to combat cancer. It also highlights the innovative use of antibodies to enhance the immune response against cancer and the importance of understanding how cancer manipulates the immune system to develop more effective treatments.